SIGNPATH PHARMA
Signpath Pharma is a development stage biotechnology company founded in 2006. Its lead compound is 99.2% pure synthesized curcumin (diferuloylmethane). Curcumin has an extensive and long history in humans as a mixture of naturally occurring curcuminoids in extracts of the root of the Curcuma longa plant. Traditional use of curcumin has been restricted to topical skin and gastrointestinal conditions because of negligible absorption when given orally. To extend its clinical use Signpath is deve... loping three different intravenous nanoparticle-sized formulations; liposomal, polymeric, and PLGA. Proof of efficacy of these formulations against human tumor xenografts in mice has been established. Following intravenous injection of each formulation, we observed transport across the blood brain barrier in mice, rats, and localization in the hippocampus, brainstem and the striatum.
SIGNPATH PHARMA
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2006-01-01
Address:
Quakertown, Pennsylvania, United States
Country:
United States
Website Url:
http://www.signpathpharma.com
Total Employee:
1+
Status:
Active
Contact:
3153833496
Total Funding:
7.29 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt WordPress Font Awesome Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Sonnet BioTherapeutics
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.signpathpharma.com
- Host name: 56.18.196.35.bc.googleusercontent.com
- IP address: 35.196.18.56
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Signpath Pharma"
About Us - Signpath Pharma
Michelle Comas joined Signpath Pharma in March 2022 as Vice President, Regulatory Affairs and Operations. Before joining Signpath, Michelle held the position of Director of Regulatory Affairs and Quality at Varex Imaging Corp., …See details»
SignPath Pharma Company Profile | Management and Employees …
Www.signpathpharma.com . Contact Information. Headquarters. 3477 Corporate Pkwy Ste 100, Center Valley, Pennsylvania, 18034, United States (215) 538-9996. SignPath Pharma Profile …See details»
SignPath Pharma Inc. - LinkedIn
SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to …See details»
SignPath Pharma - Overview, News & Similar companies - ZoomInfo
Mar 16, 2020 Popular Searches Signpath Pharma Inc Signpath Pharma Signpathpharma Signpath Pharma| Inc Sign Path Pharma Inc SIC Code 28,283 NAICS Code 32,325 Ticker …See details»
Signpath Pharma - Crunchbase Company Profile & Funding
Signpath Pharma is a development stage biotechnology company founded in 2006. Its lead compound is 99.2% pure synthesized curcumin (diferuloylmethane).See details»
SignPath Pharma Inc. Information - RocketReach
SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to …See details»
SIGNPATH PHARMA, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SIGNPATH PHARMA, INC. of Sandy, UT. Get the latest business insights from Dun & Bradstreet.See details»
SignPath Pharma, Inc. - Drug pipelines, Patents, Clinical trials
Explore SignPath Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, and 34 literature, Disease Domain:Endocrinology and ...See details»
Investor Relations - Signpath Pharma
OUTSIDE AUDITORS. Marcum LLP serve as the company’s outside auditors, and advise the Board and management on accounting issues.See details»
Signpath Pharma - PitchBook
Signpath Pharma General Information Description. Operator of a drug development platform intended to eliminate the cardiac side effects of the drugs. The company is involved in …See details»
Signpath Pharma, Inc. Details
Metrics Founded 2006 Employees Range 1-10 Number of Employees 10 Estimated Annual Revenue $1M-$10M EIN NumberSee details»
Signpath Pharma, Inc. in Sandy, UT - (215) 538-9996 - Company …
Signpath Pharma, Inc. is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number.See details»
Signpath Pharma - Craft
Signpath Pharma has 5 employees at their 1 location and $5.3 m in total funding,. See insights on Signpath Pharma including office locations, competitors, revenue, financials, executives, …See details»
Signpath Pharma - Company Profile - Tracxn
Dec 11, 2024 Signpath Pharma is a clinical stage biotechnology company that develops drugs using curcuminoids extracted from the root of the Curcuma longa plant for applications in …See details»
SignPath Pharma Inc Overview - Salary.com
Discover essential details about SignPath Pharma Inc, including address, contact, and journey of our company's evolution.See details»
Signpath Pharma - Company Information, Competitors, News
Find useful insights on Signpath Pharma's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Signpath Pharma.See details»
Signpath Pharma - VentureRadar
Similar Companies: TAHO Pharmaceuticals Ltd. Taiwan Privately Held Taihe Biotech Pharmaceutical Co., Ltd. is a biotechnology new drug development company, which is a …See details»
Patents - Signpath Pharma
Signpath has established category-wide patent protection with more than 15 issued U.S. patents and corresponding international patents. These patents protect cardiac arrhythmia, …See details»
Prevention of Cardiac Side Effects - Signpath Pharma
Chart B & C. Monitoring of QTc prolongation by 20 mg/kg oral Moxifloxacin with, and without, 20 mg/kg oral SPP4040. Moxifloxacin caused a maximal QTc prolongation of 25-30 ms …See details»